Purpose
To examine the association between use of medications and prevalence of urinary incontinence (UI) in gender-specific analyses of a community-based, representative sample.
Materials and Methods
A population-based epidemiologic study was conducted among 5,503 men and women aged 30-79 residing in Boston, Massachusetts (baseline data collected 2002-2005). Urologic symptoms were ascertained in a two-hour, in-person interview. UI was defined as urine leakage occurring weekly or more often, considering the past year. Medications used in the past month were considered ‘current use’. Associations of 20+ medications and prevalent UI were examined using multivariable logistic regression (odds ratios [ORs] and 95% confidence intervals [CIs]) with adjustments for known UI risk factors.
Results
UI prevalence in the analysis sample was 9.0% in women and 4.6% in men. Among women, prevalence was highest among users of certain antihistamines (28.4%) and angiotensin II receptor blockers (ARBs) (22.9%). Among men, prevalence was highest among ARB (22.2%) and loop diuretic (19.1%) users. After final multivariable adjustment, there were significant positive associations for certain antihistamines, beta receptor agonists, ARBs, and estrogens with UI among women (all ORs >1.7), and a borderline-significant association for anticonvulsants (OR=1.75, 95% CI: 1.00, 3.07). Among men, only anticonvulsants (OR=2.50, 95% CI: 1.24, 5.03) were associated with UI after final adjustments, although ARBs showed an adjusted association of borderline significance (OR=2.21, 95% CI: 0.96, 5.10).
Conclusion
Although a cross-sectional analysis cannot determine causality, our analysis suggests certain medications should be further examined in longitudinal analyses of risk to determine their influence on urologic symptoms.